CoChat

Effect of Statins on Fasting Plasma Glucose in Diabetic and Nondiabetic Patients

The DOI matches its Crossref record; 19 of the 20 references it cites were found in a registry or an index.

Abstract

Background: The 3-hydroxy-3-methylglutaryl-CoA reductase inhibitors (statins) reduce serum cholesterol level and cardiovascular morbidity and mortality. However, the effect of statins on glucose metabolism is unclear. Some studies have suggested that statins may cause hyperglycemia by increasing calcium concentration in the islet cells leading to decrease in insulin release or by decreasing GLUT 4-mediated peripheral glucose uptake. Methods: We analyzed the data in 345,417 patients (mean age 61 ± 15 years, 94% males, 6% diabetic, 20% statin users) from the Veterans Affairs VISN 16 database. We studied change in fasting plasma glucose (FPG) in this population over a mean time of 2 years between the first available measurement and the last measurement form the most recent recorded visit. Data were limited to patients who had 2 FPG measurements. Diagnosis of diabetes had to be present before the first FPG measurement. Results: Among patients without diabetes, FPG increased with statin use from 98 mg/dL to 105 mg/dL, and among nonstatin users, FPG increased from 97 mg/dL to 101 mg/dL (increase in FPG with statin use P < 0.0001). Among patients with diabetes, FPG increased with statin use from 102 mg/dL to 141 mg/dL, and among nonstatin users, FPG increased from 100 mg/dL to 129 mg/dL (increase in FPG with statin use; P < 0.0001). After adjustment for age and use of aspirin, β-blockers, and angiotensin-converting enzyme inhibitors, the change in FPG in nondiabetic statin users was 7 mg/dL (vs 5 mg/dL in nonstatin users, P < 0.0001) and for diabetic statin users it was 39 mg/dL (vs 32 in nonstatin users, P < 0.0001). Conclusions: Statin use is associated with a rise of FPG in patients with and without diabetes. This relationship between statin use and rise in FPG is independent of age and use of aspirin, β-blockers, and angiotensin-converting enzyme inhibitors.

Overview

Integrity signals

Registry

Crossref · 10.2310/jim.0b013e318197ec8b

Cites

19 of 19 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Citations

Cites

Show all 19 references

Research works printed but not linked: 8

  1. Scandinavian Simvastatin Survival Study Group, 1994, Lancet, 344, 1383
  2. Collins R, 2003, Lancet, 361, 2005
  3. Colhoun HM, 2004, Lancet, 9435, 685
  4. Sabatine MS, 2004, Circulation, 110, S834
  5. Nakata M, 2006, Diabetologia, 49, 1881
  6. Sever PS, 2003, Lancet, 361, 1149
  7. 10.2337/dc05-1902 · doi:10.2337/dc05-1902
  8. Levitan EB, Arch Intern Med, 2147

Cited by

See all 126

Metadata

Authors
Sukhija, R., Prayaga, S., Marashdeh, M., Bursac, Z., Kakar, P., Bansal, D., Sachdeva, R., Kesan, S. H., & Mehta, J. L.
Affiliations
  • Division of Cardiovascular Medicine, Little Rock
  • Central Arkansas Veterans Healthcare System (US)
  • University of Arkansas for Medical Sciences (US)
Venue
Journal of Investigative Medicine
Published
2009-03
Volume
57
Issue
3
Pages
495-499
ISSN
  • 1081-5589 (ISSN-L)
  • 1708-8267
OpenAlex
W121422619
Cited by
126
References
20
Citations by year
2026: 2 · 2025: 3 · 2024: 2 · 2023: 8 · 2022: 10 · 2021: 5 · 2020: 5 · 2019: 5 · 2018: 6 · 2017: 7 · 2016: 10 · 2015: 11 · 2014: 12 · 2013: 12 · 2012: 15
FWCI
9.10
Type
journal article
Language
en
Open access
closed
Licence
journals.sagepub.com/page/policies/text-and-data-mining-license (tdm)
Locations
  • Journal of Investigative Medicine (publishedVersion)
  • PubMed (publishedVersion)
Topics
  • Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Lipoproteins and Cardiovascular Health
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes, Cardiovascular Risks, and Lipoproteins
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Cancer, Lipids, and Metabolism
Keywords
statins, fasting blood glucose, hyperglycemia, diabetes mellitus, glucose metabolism, veterans, insulin secretion, adverse drug reactions
MeSH terms
Aged, Blood Glucose, Diabetes Mellitus, Fasting, Food Deprivation, Humans, Hypertension, Male, Middle Aged, United States, Veterans, Databases, Factual, Treatment Outcome, Hydroxymethylglutaryl-CoA Reductase Inhibitors, Diabetes Complications, Dyslipidemias

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Effect of Statins on Fasting Plasma Glucose in Diabetic and Nondiabetic Patients. https://app.cochat.ai/papers/10.2310/jim.0b013e318197ec8b
The paper
Sukhija, R., Prayaga, S., Marashdeh, M., Bursac, Z., Kakar, P., Bansal, D., Sachdeva, R., Kesan, S. H., & Mehta, J. L. (2009). Effect of Statins on Fasting Plasma Glucose in Diabetic and Nondiabetic Patients. Journal of Investigative Medicine. https://doi.org/10.2310/jim.0b013e318197ec8b

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.